Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E

Abstract Background Several lines of evidence suggest that high-density lipoprotein (HDL) reduces Alzheimer’s disease (AD) risk by decreasing vascular beta-amyloid (Aβ) deposition and inflammation, however, the mechanisms by which HDL improve cerebrovascular functions relevant to AD remain poorly un...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Jerome Robert, Emily B. Button, Emma M. Martin, Luke McAlary, Zoe Gidden, Megan Gilmour, Guilaine Boyce, Tara M. Caffrey, Andrew Agbay, Amanda Clark, Judith M. Silverman, Neil R. Cashman, Cheryl L. Wellington
Формат: Artigo
Язык:Inglês
Опубликовано: BMC 2020-03-01
Серии:Molecular Neurodegeneration
Предметы:
Alzheimer’s disease
Cerebrovasculature
High-density lipoprotein (HDL)
Cerebral amyloid angiopathy (CAA)
Endothelial inflammation
Apolipoprotein (apo)E
Online-ссылка:http://link.springer.com/article/10.1186/s13024-020-00366-8
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Internet

http://link.springer.com/article/10.1186/s13024-020-00366-8

Схожие документы